Pregnancy is always a special situation where every action or side effect of the drug varies when compared to a situation of a non-pregnant patient. It is not only because the pregnant woman's metabolism differs due to the hormonal and other changes happened to her, but also because every medicine or its metabolite passes to the baby and shows its action there. The only thing is, be cautious, attentive and well supervised when you take any single drug in pregnancy. The interactions can vary in pregnancy, and the dosage may differ as well. Strict supervision of the Physician is mandatory.
sponsored
You should not use Dep 37 Tablet in the I trimester of pregnancy, except in cases of extreme necessity. It should be noted that the application of Dep 37 Tablet during pregnancy may significantly change the fetal heart rate. When used in obstetrics at the doses recommended in order to facilitate childbirth, newborns, more frequently in premature infants, it may be temporary muscular hypotonia, hypothermia, respiratory failure. When the need for regular use during lactation breastfeeding should be discontinued.
Dep 37 Tablet using should be avoided in infants.
Dep 37 Tablet breastfeeding
When a drug is taken when the patient is breast feeding, a part of the drug is secreted in her breast milk and is passed to the baby. The dosage of the medicine to mother and baby are different, and many drugs actions are side effects when you take them without a disease, and what if you the baby takes them without a disease? What if the drug is contraindicated in newborns, infants or children? So, breastfeeding is a very alarming situation when the mother is on medications. Ask your Physician or Pediatrician about the effect of the drug on the baby and how much is excreted in breast milk and if it harms the baby!
UK: Use should be avoided. US: The manufacturer makes no recommendation regarding use during lactation. Excreted into human milk: Yes Comments: The effects in the nursing infant are unknown.
See references
References for pregnancy information
Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
DailyMed. "AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
PubMed Health. "Librax: This section provide the link out information of drugs collectetd in PubMed Health. ". http://www.ncbi.nlm.nih.gov/pubmedhe... (accessed September 17, 2018).
FDA Pharm Classes. "FDA Pharmacological Classification: FDA published a final rule that amended the requirements for the content and format of approved labeling (prescribing information) for human prescription drug and biological products in January 2006.". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).
Reviews
Consumer reviews
There are no reviews yet. Be the first to write one!
Information checked by Dr. Sachin Kumar, MD Pharmacology
